Recombinant Buchnera aphidicola subsp. Schizaphis graminum Protein HflK (hflK)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and serves as a useful reference.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us for preferential development.
Synonyms
hflK; BUsg_548; Protein HflK
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-411
Protein Length
full length protein
Species
Buchnera aphidicola subsp. Schizaphis graminum (strain Sg)
Target Names
hflK
Target Protein Sequence
MAWNKFNNSEPELDPWGKKNSQEKNGSKNKDDRKNHEKIITLDFKKFLYNINNIFNKTNN SQNLSKNKINPFLIIAFVSFFVWCFSGFYTIKEAERGVVTTFGKFSHLVAPGLNWRPVFI NEVKAVNVETVRELATSGVMLTSDENVVRVEMNVQYKITDPADYLFSVAYPDDSLRQATD SALRGVIGHSNMDRVLTEGRTLIRSDTQKEIEETIKPYKLGITILDVNFQTARPPEEVKE AFDDAIAARENREQYIREAEAYSNEVQPKAHGKAQRILEEAKAYSSRRILEAQGEVVRFL KILPEYRKNKEMTLKRLYIESMEKLLSKTKKIFIDKKNHSKLFLSLNNFFHQDKFNKQDL FNNPINLSKNHSCSFQKNKEINDVSSLPPSDFFKKRRIESIRTNIKNIERE
Uniprot No.

Target Background

Function
HflC and HflK may encode or regulate a protease.
Database Links
Protein Families
Band 7/mec-2 family, HflK subfamily
Subcellular Location
Membrane; Single-pass membrane protein.

Q&A

What is the HflK protein and what is its primary function in Buchnera aphidicola?

HflK is a membrane protein belonging to the SPFH (stomatin, prohibitin, flotillin, HflK/C) protein family found throughout all domains of life. In Buchnera aphidicola, an obligate endosymbiont of aphids including Schizaphis graminum, HflK likely forms a complex with HflC (together forming the HflKC complex) that regulates membrane organization and protein stability. Based on studies of homologous proteins in other bacteria like E. coli, the HflK protein in Buchnera likely regulates proteolysis by interacting with the FtsH protease, potentially influencing various cellular processes critical for the symbiotic relationship with its aphid host .

The HflKC complex in bacteria bears functional similarity to eukaryotic prohibitins (PHB1-PHB2), which form ring-like heterooligomers in mitochondrial membranes and regulate respiratory activity . This evolutionary conservation suggests the fundamental importance of HflK across different organisms despite their phylogenetic distance.

What is known about the evolutionary conservation of HflK in different Buchnera strains?

The evolutionary conservation of HflK across different Buchnera strains reflects the coevolutionary history between Buchnera and their aphid hosts. Comparative genomic analyses of Buchnera from different aphid species have revealed:

  • Core genome retention: HflK is likely part of the core genome of Buchnera (the 256 genes maintained across all lineages), suggesting its essential function in the bacterial endosymbiont .

  • Coevolutionary patterns: The phylogeny of Buchnera strains, including their protein-coding genes like hflK, generally mirrors the phylogeny of their host aphids, demonstrating parallel evolution at multiple taxonomic levels (individual, species, generic, and tribal) .

  • Sequence conservation: While some lineage-specific variations exist, functional domains of HflK are likely conserved across Buchnera strains due to selective pressure to maintain its essential biological function in the endosymbiont-host relationship.

The conservation of HflK across Buchnera strains underscores its importance in the bacterium's cellular processes and, by extension, in the symbiotic relationship with aphid hosts.

What are the recommended expression systems for producing recombinant Buchnera HflK protein?

Based on general practices for expressing membrane proteins from fastidious organisms, the following expression systems are recommended for recombinant Buchnera HflK:

E. coli-based expression systems:

  • BL21(DE3): This strain is commonly used for high-level protein expression and has been shown to successfully express SPFH family proteins.

  • C41(DE3) and C43(DE3): These strains are specifically designed for membrane protein expression and can reduce toxicity issues often encountered with membrane proteins like HflK.

Expression vectors:

  • pET series vectors with T7 promoter systems allow for controlled, high-level expression.

  • Fusion tags such as His6, MBP (maltose-binding protein), or SUMO can improve solubility and facilitate purification.

Expression conditions:

  • Lower temperatures (16-25°C) after induction are recommended to promote proper folding.

  • Induction with lower IPTG concentrations (0.1-0.5 mM) can reduce inclusion body formation.

  • Supplementing the growth medium with specific membrane-mimicking compounds can improve the yield of properly folded membrane proteins.

Table 1: Recommended Expression Systems for Recombinant Buchnera HflK

Expression SystemAdvantagesLimitationsOptimal Conditions
E. coli BL21(DE3)High expression levels, widely availablePotential toxicity18°C, 0.2 mM IPTG, 16-20h post-induction
E. coli C41(DE3)Better for toxic membrane proteinsLower yield than BL2125°C, 0.1 mM IPTG, 20-24h post-induction
E. coli C43(DE3)Designed for difficult membrane proteinsMay require optimization16°C, 0.1 mM IPTG, 24h post-induction
E. coli Lemo21(DE3)Tunable expression levelMore complex system30°C, 0.4 mM IPTG, variable L-rhamnose

What purification strategies yield the highest purity and stability for recombinant HflK protein?

Purifying membrane proteins like HflK requires specialized approaches:

Extraction from membranes:

  • Cell disruption: Sonication or French press to break cells without denaturing proteins.

  • Detergent solubilization: Mild detergents like n-dodecyl-β-D-maltoside (DDM), CHAPS, or digitonin to extract HflK from membranes.

Purification steps:

  • Affinity chromatography: If a His-tag is used, immobilized metal affinity chromatography (IMAC) with Ni-NTA resin.

  • Size exclusion chromatography: To remove aggregates and achieve higher purity.

  • Ion exchange chromatography: As a polishing step to remove remaining contaminants.

Stability considerations:

  • Maintain detergent concentration above critical micelle concentration (CMC) throughout purification.

  • Include glycerol (10-20%) in buffers to enhance protein stability.

  • Consider adding lipids during purification to maintain native-like environment.

  • Keep protein at 4°C throughout purification process.

Purity assessment:

  • SDS-PAGE analysis with Coomassie staining (for >95% purity).

  • Western blotting with anti-His or anti-HflK antibodies for specificity confirmation.

  • Mass spectrometry for final identity confirmation.

What are the main challenges in expressing and purifying functional HflK from Buchnera aphidicola, and how can they be addressed?

Main challenges:

  • Membrane protein nature: HflK is a membrane protein, making it inherently difficult to express and purify in a functional state.

    • Solution: Use specialized detergents like DDM that maintain protein folding and stability; consider nanodiscs or amphipols for improved stability.

  • Formation with partner proteins: HflK naturally forms a complex with HflC in bacteria.

    • Solution: Co-express HflK with HflC for proper complex formation and stability; alternatively, optimize conditions for stable HflK expression alone.

  • Fastidious nature of source organism: Buchnera cannot be cultured outside its host, limiting direct protein studies.

    • Solution: Use codon-optimized synthetic genes for the expression host (e.g., E. coli).

  • Protein aggregation: Overexpression may lead to inclusion body formation.

    • Solution: Lower expression temperature (16-18°C), reduce inducer concentration, use fusion partners like MBP or SUMO to enhance solubility.

  • Functional assessment: Difficult to confirm if purified protein is functionally active.

    • Solution: Develop in vitro assays such as lipid binding assays, FtsH interaction studies, or proteoliposome-based activity assessments.

Table 2: Troubleshooting Common Issues in HflK Expression and Purification

IssuePossible CauseSolution
Low expression yieldToxicity to hostUse C41/C43 strains, lower temperature, auto-induction media
Inclusion body formationRapid expression, improper foldingReduce IPTG concentration, lower temperature, add chaperones
Protein degradationProteolytic activityAdd protease inhibitors, use protease-deficient strains
Loss during purificationDetergent dilution, protein instabilityMaintain detergent above CMC, add glycerol and lipids
Inactive proteinDenaturation during purificationGentler purification methods, validation with functional assays

What is the predicted structure of HflK and how does it relate to its function in Buchnera aphidicola?

While the specific structure of Buchnera aphidicola HflK has not been experimentally determined, we can predict its structure based on homologous proteins:

Predicted structural elements:

  • N-terminal transmembrane domain: Anchors the protein to the bacterial inner membrane.

  • SPFH domain: Forms the core of the protein and mediates interactions with membrane lipids and other proteins.

  • C-terminal region: Likely involved in interactions with partner proteins, particularly HflC and FtsH protease.

Based on studies of the E. coli HflKC complex, the HflK protein likely forms part of a ring-like heterooligomeric complex in the membrane that associates with the FtsH protease. The structure resembles that of eukaryotic prohibitins (PHB1-PHB2), which form similar ring-like structures in mitochondrial membranes .

The C-terminal extension of HflK, which is not present in HflC, appears to be particularly important for function, as it interacts with FtsH and is likely critical for assembly of the HflKC-FtsH complex. This structural feature may explain why HflK alone can largely carry out the function of the HflKC complex in E. coli .

How does HflK interact with other proteins in Buchnera, and what functional complexes does it form?

Based on studies of homologous proteins in E. coli and other bacteria, HflK from Buchnera aphidicola likely participates in several key protein-protein interactions:

  • HflK-HflC complex: The primary interaction partner of HflK is HflC, forming the HflKC complex that regulates membrane organization and protein stability. This complex typically contains equal numbers of HflK and HflC subunits arranged in a ring-like structure .

  • HflKC-FtsH interaction: The HflKC complex likely regulates the activity of FtsH, an AAA+ metalloprotease involved in protein quality control. Studies in E. coli have shown that HflK, particularly its C-terminal extension, interacts with FtsH . This interaction may modulate FtsH protease activity, thereby influencing the stability of various membrane and cytoplasmic proteins.

  • Potential regulatory targets: By regulating FtsH activity, the HflKC complex indirectly affects the stability of proteins degraded by FtsH. In E. coli, one such protein is IspG, an enzyme involved in isoprenoid biosynthesis . In Buchnera, which has a reduced genome, the specific targets may differ but likely include proteins essential for the endosymbiotic lifestyle.

The functional significance of these interactions in Buchnera may relate to the bacterium's role as an endosymbiont, potentially influencing metabolic processes important for providing nutrients to the aphid host.

What post-translational modifications have been identified in HflK, and how do they affect its function?

Potential post-translational modifications:

  • Phosphorylation: Bacterial membrane proteins, including SPFH family members, can be phosphorylated at serine, threonine, or tyrosine residues, affecting their interactions with other proteins or their conformational states.

  • Proteolytic processing: Some membrane proteins undergo N-terminal processing during membrane insertion. If present in HflK, this would affect the mature protein's size and potentially its function.

  • Lipid modifications: Given its membrane association, HflK might undergo lipid modifications that enhance membrane anchoring or influence interactions with specific membrane domains.

Functional effects:

  • PTMs could modulate HflK's interaction with HflC, FtsH, or other proteins.

  • They might regulate the assembly, stability, or activity of the HflKC complex.

  • In Buchnera's context as an endosymbiont, PTMs could potentially respond to signals from the aphid host, allowing for coordinated regulation of bacterial processes.

Further experimental studies would be needed to confirm the presence and functional significance of these potential modifications in Buchnera HflK.

What are the recommended methods for assessing HflK-mediated protein regulation in experimental settings?

Assessing HflK-mediated protein regulation requires approaches that can detect changes in protein stability and abundance:

In vivo approaches:

  • Genetic manipulation: Create knockout or conditional mutants of hflK in model organisms (since Buchnera cannot be cultured). Compare protein profiles between wild-type and mutant strains using proteomic approaches .

  • Reporter systems: Construct fusion proteins of potential HflK regulatory targets with fluorescent or enzymatic reporters to monitor their stability in the presence or absence of HflK.

  • Complementation studies: Express Buchnera hflK in E. coli hflK mutants to assess functional conservation and identify specific regulatory targets .

In vitro approaches:

  • Reconstituted protease assays: Purify HflK, HflC, and FtsH proteins to reconstitute the regulatory complex in vitro. Add potential substrate proteins and monitor their degradation rates.

  • Pull-down assays: Use purified HflK as bait to identify interacting proteins from bacterial lysates, followed by mass spectrometry identification.

  • Surface plasmon resonance (SPR) or isothermal titration calorimetry (ITC): Quantitatively measure binding affinities between HflK and its interaction partners or between the HflKC complex and target proteins.

Table 3: Comparative Analysis of Methods for Studying HflK-Mediated Protein Regulation

MethodAdvantagesLimitationsKey Parameters to Monitor
Proteomics comparisonComprehensive, unbiasedRequires sophisticated equipmentProtein abundance changes between WT and ΔhflK
Reporter fusion systemsReal-time monitoring possibleFusion may affect native regulationFluorescence/enzymatic activity over time
In vitro degradation assaysDirect measurement of activityArtificial conditionsSubstrate degradation rates with/without HflK
Pull-down and MS analysisIdentifies novel interactionsMay capture non-physiological interactionsProteins specifically enriched with HflK bait
Complementation studiesTests functional conservationMay not fully restore functionGrowth rates, protein profiles of complemented strains

How can researchers differentiate between the roles of HflK and HflC in experimental systems?

Differentiating between HflK and HflC functions requires targeted experimental approaches:

Genetic approaches:

  • Individual gene knockouts: Create separate knockout strains for hflK and hflC, as well as a double knockout. Based on E. coli studies, deletion of hflK causes phenotypes similar to the double knockout, while hflC deletion has minimal effects .

  • Complementation experiments: Express either HflK or HflC in the double knockout strain to determine if either protein alone can restore wild-type phenotypes. In E. coli, HflK alone can largely carry out the function of the HflKC complex .

  • Domain swapping: Create chimeric proteins with domains exchanged between HflK and HflC to identify which regions are responsible for specific functions.

Biochemical approaches:

  • Individual protein purification: Purify HflK and HflC separately and assess their individual activities in assays such as lipid binding, protein interaction studies, or FtsH regulation.

  • Structural studies: Use techniques like cryo-EM or X-ray crystallography to determine the structures of HflK and HflC individually and in complex to identify unique structural features.

  • Specific antibodies: Develop antibodies that specifically recognize either HflK or HflC to study their localization, abundance, and interactions independently.

Expression analysis:

  • Promoter studies: Analyze the promoter regions of hflK and hflC to determine if they are co-regulated or independently regulated.

  • Transcriptomic analysis: Use RNA sequencing to identify genes differentially expressed in hflK versus hflC deletion strains, providing insights into their distinct regulatory roles.

What in vitro systems can be used to study HflK function when working with the unculturable Buchnera endosymbiont?

Studying proteins from unculturable organisms like Buchnera presents unique challenges, but several in vitro systems can be employed:

Heterologous expression systems:

  • E. coli-based systems: Express recombinant Buchnera HflK in E. coli using codon-optimized synthetic genes. This approach can be used for protein purification and functional studies .

  • Cell-free protein synthesis: Use cell-free expression systems to produce Buchnera HflK without the constraints of cellular toxicity or growth limitations.

  • Yeast expression systems: Express Buchnera HflK in yeast, which might provide a more eukaryotic-like environment for protein folding and interactions.

Reconstituted membrane systems:

  • Proteoliposomes: Incorporate purified HflK into artificial lipid vesicles to study its membrane association and function.

  • Nanodiscs: Use membrane nanodiscs, which provide a defined lipid environment for membrane proteins, to study HflK structure and function.

  • Planar lipid bilayers: Incorporate HflK into planar lipid bilayers for electrical or spectroscopic measurements.

Hybrid systems:

  • HflK from Buchnera with partner proteins from model organisms: Study the interaction between Buchnera HflK and well-characterized proteins like E. coli FtsH to infer functional conservation.

  • Chimeric proteins: Create fusion proteins combining domains from Buchnera HflK with those from homologous proteins in cultivable bacteria.

  • Artificial gene circuits: Design synthetic genetic circuits in model organisms that incorporate Buchnera hflK to study its regulatory functions.

How does the HflK-HflC complex in Buchnera influence the endosymbiotic relationship with aphids?

The HflK-HflC complex may play crucial roles in the Buchnera-aphid symbiosis, influencing:

Metabolic regulation:

  • By regulating protein stability through FtsH protease interaction, the HflK-HflC complex might control key metabolic enzymes involved in synthesizing essential nutrients for the aphid host.

  • Based on studies in E. coli, where the HflKC complex affects levels of IspG (an enzyme in the isoprenoid biosynthetic pathway leading to ubiquinone production) , a similar regulatory mechanism might exist in Buchnera, potentially influencing metabolic pathways critical for generating nutrients required by the aphid host.

Stress response and adaptation:

  • The complex may help Buchnera adapt to the unique environment of aphid bacteriocytes by regulating stress response proteins.

  • It might contribute to maintaining proteostasis within the limited genetic repertoire of the endosymbiont, which has undergone significant genome reduction during evolution .

Developmental synchronization:

  • The regulatory functions of the HflK-HflC complex could help synchronize Buchnera cellular processes with aphid developmental stages.

  • This synchronization would be crucial for coordinating nutrient provision to the host during different life stages.

Evolutionary implications:

  • The coevolution between Buchnera and aphids suggests that the HflK-HflC complex has been maintained due to its essential function in the symbiotic relationship.

  • Comparative genomic analyses showing conservation of the hflK gene across Buchnera strains would support this hypothesis.

What are the differences in respiratory regulation between the HflK-HflC complex in Buchnera and its homologs in other bacteria?

The respiratory regulation function of the HflK-HflC complex likely differs between Buchnera and free-living bacteria due to:

Genomic and metabolic context:

  • Buchnera has undergone extensive genome reduction, retaining only essential genes for its endosymbiotic lifestyle .

  • The respiratory chain in Buchnera may be simplified compared to free-living bacteria like E. coli, potentially altering the regulatory role of the HflK-HflC complex.

In E. coli, the HflK-HflC complex:

  • Regulates aerobic respiration by influencing the levels of IspG, affecting ubiquinone biosynthesis.

  • Impacts the expression of cytochrome quinol oxidases (CyoABCD and CydAB), which are used under aerobic and microaerobic conditions, respectively .

In Buchnera, potential differences include:

  • Simpler respiratory chain with fewer components to regulate.

  • Potentially different target proteins for regulation, reflecting the specialized metabolic needs of the endosymbiont.

  • Possible coordination with host metabolism, as the endosymbiont's respiration must function within the aphid bacteriocyte environment.

  • Different energy demands and oxygen availability in the intracellular environment compared to free-living bacteria.

Comparative analysis:

  • Structural conservation of key domains despite sequence divergence might indicate functional conservation of the basic regulatory mechanism.

  • Differences in interacting partners and regulatory targets would reflect adaptation to the endosymbiotic lifestyle.

  • The regulatory mechanism might be more streamlined in Buchnera, focusing on essential functions relevant to the symbiotic relationship.

What novel therapeutic approaches could target the HflK-HflC complex in pathogenic bacteria based on insights from Buchnera research?

While Buchnera is not pathogenic, research on its HflK-HflC complex could inform therapeutic approaches against bacterial pathogens:

Potential therapeutic strategies:

  • Inhibition of HflK-HflC complex formation:

    • Small molecule inhibitors disrupting HflK-HflC interaction could dysregulate bacterial respiration.

    • Peptide-based inhibitors mimicking interaction interfaces could specifically target the complex.

  • Modulation of FtsH protease activity:

    • Compounds altering the regulatory interaction between HflK-HflC and FtsH could lead to proteostasis disruption.

    • This approach might be particularly effective against bacteria where the HflK-HflC complex regulates virulence factors.

  • Targeting the unique C-terminal extension of HflK:

    • Since this region appears critical for function , it presents a specific target for intervention.

    • Antibodies or aptamers recognizing this region could disrupt HflK function.

Advantages of targeting HflK-HflC:

  • Conservation across bacteria:

    • SPFH proteins like HflK are widely conserved bacterial proteins, offering potentially broad-spectrum targets.

  • Essentiality under stress conditions:

    • In E. coli, the HflK-HflC complex is particularly important under high aeration conditions , suggesting targeting might be effective during specific infection stages.

  • Limited homology to human proteins:

    • Despite distant relationship to eukaryotic prohibitins, sufficient differences exist to potentially develop selective inhibitors.

Table 4: Potential Therapeutic Approaches Targeting HflK-HflC Complex

ApproachTargetPotential EffectAdvantageChallenge
Small molecule inhibitorsHflK-HflC interfaceDisrupt complex formationMay affect multiple bacteriaSpecificity across bacterial species
Peptide mimeticsC-terminal extension of HflKPrevent FtsH interactionHigher specificityCellular penetration issues
Allosteric modulatorsConformational states of HflKAlter regulatory functionMay work at lower concentrationsComplex pharmacodynamics
Anti-HflK antibodiesSurface-exposed epitopesNeutralize functionHigh specificityDelivery to intracellular bacteria
Gene silencing approacheshflK mRNAReduce protein expressionTargeted approachDelivery challenges

What are the most significant research gaps in our understanding of HflK in Buchnera aphidicola?

Despite advances in understanding bacterial SPFH proteins, several significant knowledge gaps remain regarding HflK in Buchnera aphidicola:

  • Structural characterization: No experimental structure exists for Buchnera HflK, limiting our understanding of its specific functional mechanisms.

  • Specific regulatory targets: The exact proteins regulated by the HflK-HflC complex in Buchnera remain unidentified, though they likely differ from those in free-living bacteria due to genome reduction.

  • Host-symbiont interaction: How the HflK-HflC complex in Buchnera responds to signals from the aphid host is poorly understood.

  • Evolutionary trajectory: Detailed analysis of how the HflK protein has evolved in Buchnera compared to free-living relatives would provide insights into its specialized function in the endosymbiont.

  • Functional validation: Direct experimental validation of HflK function in Buchnera is challenging due to the unculturable nature of the bacterium.

Addressing these gaps would provide critical insights into the molecular mechanisms underlying the Buchnera-aphid symbiosis and bacterial membrane protein evolution in endosymbionts.

What emerging technologies might advance our understanding of HflK function in obligate endosymbionts like Buchnera?

Several cutting-edge technologies show promise for studying proteins like HflK in unculturable endosymbionts:

  • Cryo-electron tomography: This technique could visualize the HflK-HflC complex in situ within Buchnera cells inside aphid bacteriocytes, providing structural insights in the native cellular context.

  • Single-cell proteomics: Advances in mass spectrometry sensitivity could enable protein analysis from individual bacteriocytes, allowing assessment of HflK abundance and interactions.

  • CRISPR-based approaches: While direct genetic manipulation of Buchnera remains challenging, CRISPR technology could potentially be adapted for precise genetic modification of endosymbionts.

  • Organoid systems: Development of aphid bacteriocyte organoids could provide more accessible experimental systems for studying Buchnera and its proteins.

  • Computational approaches: Advanced machine learning algorithms could predict HflK structure, function, and interactions based on limited experimental data, guiding targeted experiments.

  • Synthetic biology: Reconstitution of minimal Buchnera systems in cultivable bacteria could allow functional studies of HflK in a more accessible experimental framework.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.